A-Labs Capital II Corp. is a Canada-based capital pool company. The principal business of the Company is to identify and evaluate assets or businesses with a view to potentially acquiring them or an interest therein by completing a purchase transaction, exercising an option or by any concomitant transaction. The purpose of such an acquisition is to satisfy the related conditions of a qualifying transaction under the exchange rules.

Employees

Sector

Investment Holding Companies

More about the company

Income Statement and Estimates

More financial data

Market Closed - Toronto S.E. Other stock markets 11:21:45 2026-02-27 am EST			5-day change	1st Jan Change
0.0600 ^CAD	-25.00%		-.--%	-

Mar. 18	A-Labs Capital II Corp. Announces Resignation of Director Alexandre Poirier Boivin, Effective March 16, 2026	CI
Dec. 07	A-Labs Capital II Corp. announced that it expects to receive CAD 0.15 million in funding	CI

Capitalization	124K 90.54K 76.69K 70.57K 66.79K 8.38M 126K 826K 324K 4.06M 340K 333K 14.31M	P/E ratio 2023	-8.5x	P/E ratio 2024	-10.2x
Enterprise value	149K 109K 92.02K 84.67K 80.13K 10.05M 151K 992K 389K 4.87M 407K 399K 17.17M	EV / Sales 2023	-	EV / Sales 2024	-
Free-Float	58.35%	Yield 2023 *	-	Yield 2024	-

Mar. 18	A-Labs Capital II Corp. Announces Resignation of Director Alexandre Poirier Boivin, Effective March 16, 2026	CI
Dec. 07	A-Labs Capital II Corp. announced that it expects to receive CAD 0.15 million in funding	CI
Nov. 25	A-Labs Capital II Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
Nov. 25	A-Labs Capital II Corp. Announces Board Changes	CI
Nov. 25	A-Labs Capital II Corp. Announces CEO Changes	CI
Nov. 25	A-Labs Capital II Corp. Announces CFO Changes	CI
25-08-16	A-Labs Capital II Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
25-05-28	A-Labs Capital II Corp. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
25-04-24	A-Labs Capital II Corp. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25-04-23	A-Labs Capital II Corp. Auditor Raises 'Going Concern' Doubt	CI
24-11-21	A-Labs Capital II Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
24-08-26	A-Labs Capital II Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
24-05-23	A-Labs Capital II Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

25-07-30	Canadian Investment Regulatory Organization Trade Resumption - ALAB.P	AQ
25-07-28	A-Labs Capital II Corp Announces Application for Resumption of Trading	AQ
25-03-07	A-Labs Capital II Corp. Announces Non-Convertible Loan and Change of Auditor	AQ
23-10-27	A-Labs Capital II Corp. Provides Corporate Update	AQ
23-04-11	A-Labs Capital II Corp. Announces Termination of Qualifying Transaction with Orcanos Ltd.	AQ

A-Labs Capital II Corp. Stock

Equities

ALAB.P

CA00167A1066

Investment Holding Companies

Valuation: A-Labs Capital II Corp.

Chart: A-Labs Capital II Corp.

Latest news: A-Labs Capital II Corp.

Press Releases: A-Labs Capital II Corp.

Quotes and Performance

Course Extremes

Managers and Directors: A-Labs Capital II Corp.

Shell Companies

Financials

Company Profile

Income Statement and Estimates

Current year	0.06	0.15
1 year	0.04	0.15
3 years	0.04	0.15
5 years	0.04	0.15
10 years	0.04	0.2

Manager	Title	Age	Since
Sebastian Wahl CEO	Chief Executive Officer	-	2025-11-24
Tak Tsan Tso DFI	Director of Finance/CFO	36	2025-11-24

Director	Title	Age	Since
Konstantin Lichtenwald BRD	Director/Board Member	42	2019-12-18
Sebastian Wahl BRD	Director/Board Member	-	2025-11-24
Tak Tsan Tso BRD	Director/Board Member	36	2025-11-24

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
A-LABS CAPITAL II CORP.	-25.00%	-.--%	-47.83%	-47.83%	178K
PRIME BEING CORP.	-23.17%	0.00%	+59.20%	+788.39%	1.44B
CHURCHILL CAPITAL CORP VII	-0.30%	-.--%	-.--%	-1.67%	915M
DRUGS MADE IN AMERICA ACQUISITION II CORP.	0.00%	+0.15%	-	-	656M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	-.--%	-.--%	-.--%	600M
BAIN CAPITAL GSS INVESTMENT CORP.	+0.39%	+0.49%	-	-	594M
CANTOR EQUITY PARTNERS IV, INC.	+0.59%	+0.69%	-	-	587M
CHURCHILL CAPITAL CORP XI	+0.05%	-0.10%	-	-	568M
AMERICAN EXCEPTIONALISM ACQUISITION CORP. A	-0.54%	+0.72%	-	-	551M
NEW AMERICA ACQUISITION I CORP.	+0.10%	+0.60%	-	-	501M
Average	-4.79%	+0.26%	+2.84%	+184.72%	641.3M
Weighted average by Cap.	-5.20%	+0.22%	+28.86%	+383.89%

	2023	2024
Net sales	-	-
Net income	-27.92K -20.42K -17.3K -15.92K -15.07K -1.89M -28.41K -186K -73.1K -916K -76.61K -75.02K -3.23M	-23.16K -16.94K -14.35K -13.2K -12.49K -1.57M -23.56K -155K -60.63K -760K -63.54K -62.21K -2.68M
Net Debt	11.56K 8.46K 7.16K 6.59K 6.24K 782K 11.76K 77.19K 30.27K 379K 31.72K 31.06K 1.34M	24.73K 18.09K 15.32K 14.1K 13.34K 1.67M 25.17K 165K 64.75K 811K 67.86K 66.45K 2.86M

1 day	-25.00%
3 months	-45.45%
6 months	+9.09%